FEATURE ARTICLES
Eli Lilly and Company's one-team mindset aims to templatize facility design while remaining nimble enough to react to new manufacturing breakthroughs.
- How To Implement Post-Approval Changes On A Global Level
- March 2026 — CDMO Opportunities And Threats Report
- From Principles To Practice: Building Quality Into Generative AI-Assisted Pharma Operations
- Lilly's Toolbox For Fast Track Fill Finish Sites
- From QM To QMM For AI-Assisted Pharmaceutical Manufacturing Operations
- 4 Facility Considerations for API Manufacturing
- Ever Wonder What Running A $50B Capital Facilities Project Feels Like?
PHARMA ONLINE WHITE PAPERS
-
![DNA Helix GettyImages-1421515036]( "Improving Gene Therapy Development With Organ-On-A-Chip Technology")
Improving Gene Therapy Development With Organ-On-A-Chip TechnologyExplore the current challenges of developing gene therapies, the potential of Organ-on-a-Chip technology, the future of gene therapy, and more.
-
The Roadmap To Asset Performance Management In Life Sciences8/12/2025
Find out how asset performance management boosts reliability, compliance, and efficiency in life sciences, which guides organizations from reactive fixes to predictive optimization.
-
Generate CHO-K1 GFP-Expressing Cells For Cell Line Development Workflow11/7/2025
Discover a high-efficiency workflow for generating GFP-expressing CHO-K1 clones using automated single-cell dispensing to achieve 93% isolation success and stable expression in under five weeks.
-
The Problem With Construction Quality10/21/2024
Data center construction quality management is inadequate, with issues traced to human error. A stronger focus on quality control and assurance is needed for success.
-
The State Of Digital Maturity In Pharma And Medtech Manufacturing9/20/2024
Explore results from a study aiming to understand why numerous companies continue to rely on manual, paper-based systems, and gain insight into how your competitors are gaining a competitive advantage.
-
Why Compliance-Driven CDMOs Win Sponsor Contracts2/5/2026
Learn how digital maturity and compliance excellence are reshaping CDMO competitiveness, as well as strategies that strengthen performance and accelerate tech transfers.
PHARMA ONLINE APP NOTES & CASE STUDIES
- Overcoming Bispecific Antibody Purification Challenges
- Innovating The mAb Characterization Process
- Simultaneous Extraction Of Mycoplasma, MMV, And Vesivirus Nucleic Acids From A Single Sample
- Streamline Your Fill And Finish Process Of Ready-To-Use Cartridges
- Automating High-Throughput Screens Using Patient-Derived Organoids
NEWSLETTER ARCHIVE
- 04.18.26 -- Quality Assurance Product Showcase
- 04.17.26 -- De-Risk Your Small Molecule Program
- 04.16.26 -- From Principles To Practice: Building Quality Into Generative AI-Assisted Pharma Operations
- 04.16.26 -- STREAM Edition: Batch Vs. Continuous Process Evolution
- 04.15.26 -- Innovation That's Redefining Aseptic Filling
INDUSTRY NEWS
-
![FDA Logo on phone screen-GettyImages-2208861549]( "Høeg In, Pazdur Out At The FDA")
Høeg In, Pazdur Out At The FDAWhat an eventful week it has been at the FDA, with Richard Pazdur, M.D., resigning after weeks in his position as director of Center for Drug Research and Evaluation (CDER), and his vacancy being quickly filled by acting director Tracy Beth Høeg, M.D.
-
![business peope negotiating-GettyImages-637902194]( "9 Drugs Granted Fast Track By FDA's Voucher Program")
9 Drugs Granted Fast Track By FDA's Voucher ProgramWith targets like pancreatic cancer, deafness, blindness, infertility and vaping addiction, these drugs were chosen due to an unmet need, addressing a public health crisis, boosting domestic manufacturing or increasing affordability.
-
![Pharmaceutical sorting machine, pills-GettyImages-1499814881]( "Leaders In The Excipient Market: Region And Type")
Leaders In The Excipient Market: Region And TypeThough North America led the market with a 38.32% market share of $3.15 billion in 2024, Asia Pacific is expected to have the fastest growth in the upcoming years.
-
![GettyImages-2189405678-GLP-1-obesity]( "Pfizer Strengthens Obesity Foothold With Metsera Acquisition")
Pfizer Strengthens Obesity Foothold With Metsera AcquisitionAfter discouraging efforts to bring two oral obesity drugs to market—danuglipron and lotiglipron—this acquisition launches Pfizer back into the obesity therapeutic game.
-
![weight loss, diabetes, insulin pen-GettyImages-2196049931]( "FDA Cracks Down On GLP-1 Imports")
FDA Cracks Down On GLP-1 ImportsGLP-1 bulk drug substances must be detained without physical examination (DWPE) unless they are on a list (Green List) of approved foreign GLP-1 manufacturers.
PHARMACEUTICAL ONLINE CONTENT COLLECTIONS
Explore how sterility assurance, including sterilization validation and environmental monitoring, is essential for controlling microbial contamination in mammalian cell production to ensure patient safety. Check out the latest e-book from Pharmaceutical Online.
More Content CollectionsSUPPLIER NEWS
-
Antares Vision Group To Present Denester-Inspection-Labeling Line For Prefilled Syringes At INTERPHEX 2026 Conference4/17/2026
Antares Vision Group will offer live demonstrations of an integrated line providing automatic denesting, inspection and labeling for prefilled syringe production at Interphex Booth 2821.
-
Flow Sciences Appoints Kent Lupino As Chief Marketing Officer4/14/2026
Flow Sciences, Inc., a global leader in advanced containment solutions for laboratory and pharmaceutical environments, today announced the appointment of Kent Lupino as chief marketing officer. Lupino will be based at the company's new office in North Carolina's Research Triangle Park (RTP) and will report directly to Chief Executive Officer Jonathan Mann.
-
Groninger To Debut "Lifecycle Solutions" At INTERPHEX 20264/14/2026
At the show, groninger USA will debut its newly launched service concept, “Lifecycle Solutions.” The program consolidates all services across the entire lifecycle of the company’s machines – from commissioning and continuous optimization to modernization and retrofit. In doing so, it reflects the company’s ongoing commitment to service, quality, and providing long-term solutions availability.
